Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Song, Byoung Joon ^a   Abdelmegeed, Mohamed A ^a   Henderson, Lauren E ^a   Yoo, Seong Ho ^a,b   Wan, Jie ^a   Purohit, Vishnudutt ^c   Hardwick, James P ^d   Moon, Kwan Hoon ^a,e  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Seoul National University   (South Korea)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE APPROACH; HYPERCHOLESTEROLEMIA; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL PROTEIN; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE MODIFICATION; SUBCELLULAR ORGANELLES; TRANSLATIONAL RESEARCH;

COENZYMES; MOLECULAR BIOLOGY; TISSUE;

PROTEINS;

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATE; BIOTIN; CATALASE; CYSTEINE; GLUTATHIONE; HISTONE; LIPID PEROXIDE; MALEIMIDE DERIVATIVE; MALONALDEHYDE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; REACTIVE NITROGEN SPECIES;

ALCOHOLIC FATTY LIVER; CELL ORGANELLE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY RESOURCE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; LONGEVITY; METABOLIC SYNDROME X; NITRATION; NITROSYLATION; NITROXIDATIVE STRESS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATION; OXIDATIVE STRESS; PROTEOMICS; RESPIRATORY CHAIN; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; FATTY LIVER; HUMAN; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PROTEOMICS; REACTIVE NITROGEN SPECIES;

EID: 84877302779     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/781050     Document Type: Review

References (146)

1. Soboll S., Regulation of energy metabolism in liver. Journal of Bioenergetics and Biomembranes 1995 27 6 571 582 2-s2.0-0029563613 10.1007/BF02111655 (Pubitemid 26001615)
2. Fromenty B., Pessayre D., Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacology and Therapeutics 1995 67 1 101 154 2-s2.0-0029127584 10.1016/0163-7258(95)00012-6
3. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology 2010 11 10 700 714 2-s2.0-77957105977 10.1038/nrm2970
4. Lieber C. S., Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004 34 1 9 19 2-s2.0-12844288099 10.1016/j.alcohol.2004.07.008 (Pubitemid 40163989)
5. Gao B., Bataller R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011 141 5 1572 1585
6. Preedy V. R., Patel V. B., Why H. J. F., Corbett J. M., Dunn M. J., Richardson P. J., Alcohol and the heart: biochemical alterations. Cardiovascular Research 1996 31 1 139 147 2-s2.0-0029885685 10.1016/0008-6363(95)00184-0 (Pubitemid 26093062)
7. Harper C., The neuropathology of alcohol-related brain damage. Alcohol and Alcoholism 2009 44 2 136 140 2-s2.0-61449209903 10.1093/alcalc/agn102
8. Vonlaufen A., Wilson J. S., Pirola R. C., Apte M. V., Role of alcohol metabolism in chronic pancreatitis. Alcohol Research and Health 2007 30 1 48 54 2-s2.0-34547492329
9. Diehl A. M., Goodman Z., Ishak K. G., Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988 95 4 1056 1062 2-s2.0-0023801758
10. Powell C. L., Kosyk O., Bradford B. U., Parker J. S., Lobenhofer E. K., Denda A., Uematsu F., Nakae D., Rusyn I., Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury. Hepatology 2005 42 5 1137 1147 2-s2.0-30944456159 10.1002/hep.20910 (Pubitemid 43112681)
11. Otani K., Korenaga M., Beard M. R., Li K., Qian T., Showalter L. A., Singh A. K., Wang T., Weinman S. A., Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005 128 1 96 107 2-s2.0-11144342818 10.1053/j.gastro.2004.10.045 (Pubitemid 40039962)
12. Begriche K., Igoudjil A., Pessayre D., Fromenty B., Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006 6 1 1 38 2-s2.0-32844458032 10.1016/j.mito.2005.10.004 (Pubitemid 43250588)
13. Kunos G., Osei-Hyiaman D., Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis. American Journal of Physiology 2008 294 5 G1101 G1104 2-s2.0-45849112141 10.1152/ajpgi.00057.2008
14. Sudheer A. R., Muthukumaran S., Devipriya N., Devaraj H., Menon V. P., Influence of ferulic acid on nicotine-induced lipid peroxidation, DNA damage and inflammation in experimental rats as compared to N -acetylcysteine. Toxicology 2008 243 3 317 329 2-s2.0-37149024116 10.1016/j.tox.2007.10.016 (Pubitemid 50009669)
15. Moon K. H., Upreti V. V., Yu L. R., Lee I. J., Ye X., Eddington N. D., Veenstra T. D., Song B. J., Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 2008 8 18 3906 3918 2-s2.0-53549125568 10.1002/pmic.200800215
16. Cerretani D., Riezzo I., Fiaschi A. I., Centini F., Giorgi G., D'Errico S., Fiore C., Karch S. B., Neri M., Pomara C., Turillazzi E., Fineschi V., Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model. International Journal of Legal Medicine 2008 122 6 461 469 2-s2.0-53849126106 10.1007/s00414-008-0262-2
17. Song B. J., Moon K. H., Upreti V. V., Eddington N. D., Lee I. J., Mechanisms of mdma (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Current Pharmaceutical Biotechnology 2010 11 5 434 443 2-s2.0-77956563187 10.2174/138920110791591436
18. Carvalho M., Pontes H., Remião F., Bastos M. L., Carvalho F., Mechanisms underlying the hepatotoxic effects of ecstasy. Current Pharmaceutical Biotechnology 2010 11 5 476 495 2-s2.0-77956575319 10.2174/138920110791591535
19. Turillazzi E., Riezzo I., Neri M., Bello S., Fineschi V., MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings. Current Pharmaceutical Biotechnology 2010 11 5 500 509 2-s2.0-77956568445 10.2174/138920110791591481
20. Fromenty B., Pessayre D., Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. Journal of Hepatology 1997 26 2 43 53 2-s2.0-0030917702
21. Wang Y., Seitz H. K., Wang X. D., Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcoholism 2010 34 3 567 573 2-s2.0-77749295136 10.1111/j.1530-0277.2009.01122.x
22. Day C. P., Bashir R., James O. F. W., Bassendine M. F., Crabb D. W., Thomasson H. R., Li T. K., Edenberg H. J., Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991 14 5 798 801 2-s2.0-0025787727 10.1002/hep.1840140509
23. Yokoyama A., Muramatsu T., Ohmori T., Yokoyama T., Okuyama K., Takahashi H., Hasegawa Y., Higuchi S., Maruyama K., Shirakura K., Ishii H., Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 1998 19 8 1383 1387 2-s2.0-0031709015 10.1093/carcin/19.8.1383 (Pubitemid 28409835)
24. Muto M., Hitomi Y., Ohtsu A., Ebihara S., Yoshida S., Esumi H., Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut 2000 47 2 256 261 2-s2.0-0033915067 10.1136/gut.47.2.256 (Pubitemid 30489770)
25. Brooks P. J., Enoch M. A., Goldman D., Li T. K., Yokoyama A., The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Medicine 2009 6 3 e50 2-s2.0-63449093534
26. Hoek J. B., Cahill A., Pastorino J. G., Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 2002 122 7 2049 2063 2-s2.0-0036083422 (Pubitemid 34651446)
27. Wallace D. C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics 2005 39 359 407 2-s2.0-23844558266 10.1146/annurev.genet.39.110304. 095751 (Pubitemid 43011120)
28. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006 443 7113 787 795 2-s2.0-33750347347 10.1038/nature05292 (Pubitemid 44622683)
29. Monsalve M., Borniquel S., Valle I., Lamas S., Mitochondrial dysfunction in human pathologies. Frontiers in Bioscience 2007 12 3 1131 1153 2-s2.0-34249819676 10.2741/2132 (Pubitemid 46850646)
30. Wallace K. B., Mitochondrial off targets of drug therapy. Trends in Pharmacological Sciences 2008 29 7 361 366 2-s2.0-45849132031 10.1016/j.tips.2008.04.001
31. Chandra D., Singh K. K., Genetic insights into OXPHOS defect and its role in cancer. Biochimica et Biophysica Acta 2011 1807 6 620 625 2-s2.0-79955604131 10.1016/j.bbabio.2010.10.023
32. Boveris A., Chance B., The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochemical Journal 1973 134 3 707 716 2-s2.0-0015882341
33. Hamanaka R. B., Chandel N. S., Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences 2010 35 9 505 513 2-s2.0-77956186783 10.1016/j.tibs.2010. 04.002
34. Bailey S. M., Pietsch E. C., Cunningham C. C., Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radical Biology and Medicine 1999 27 7-8 891 900 2-s2.0-0032847556 10.1016/S0891-5849(99)00138-0 (Pubitemid 29454593)
35. Fernández-Checa J. C., Kaplowitz N., García-Ruiz C., Colell A., Mitochondrial glutathione: importance and transport. Seminars in Liver Disease 1998 18 4 389 401 2-s2.0-0032406895 (Pubitemid 29011042)
36. Caldwell S. H., de Freitas L. A. R., Park S. H., Moreno M. L. V., Redick J. A., Davis C. A., Sisson B. J., Patrie J. T., Cotrim H., Argo C. K., Al-Osaimi A., Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2009 49 6 1888 1895 2-s2.0-68949086361 10.1002/hep.22851
37. Campello S., Scorrano L., Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Reports 2010 11 9 678 684 2-s2.0-77956230098 10.1038/embor.2010.115
38. Caro A. A., Cederbaum A. I., Oxidative stress, toxicology, and pharmacology of CYP2E1. Annual Review of Pharmacology and Toxicology 2004 44 27 42 2-s2.0-1342323673 10.1146/annurev.pharmtox.44.101802.121704 (Pubitemid 38263832)
39. Purohit V., Gao B., Song B. J., Molecular mechanisms of alcoholic fatty liver. Alcoholism 2009 33 2 191 205 2-s2.0-58849156556 10.1111/j.1530-0277.2008. 00827.x
40. Cohen J. I., Chen X., Nagy L. E., Redox signaling and the innate immune system in alcoholic liver disease. Antioxidants and Redox Signaling 2011 15 2 523 534 2-s2.0-79959497081 10.1089/ars.2010.3746
41. McKim S. E., Gäbele E., Isayama F., Lambert J. C., Tucker L. M., Wheeler M. D., Connor H. D., Mason R. P., Doll M. A., Hein D. W., Arteel G. E., Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 2003 125 6 1834 1844 2-s2.0-10744232492 10.1053/j.gastro.2003.08.030 (Pubitemid 37500447)
42. Venkatraman A., Shiva S., Wigley A., Ulasova E., Chhieng D., Bailey S. M., Darley-Usmar V. M., The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 2004 40 3 565 573 2-s2.0-4544327270 10.1002/hep.20326 (Pubitemid 39265577)
43. Purohit V., Rapaka R., Kwon O. S., Song B. J., Role of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sciences 2013 92 1 3 9
44. Bansal S., Liu C. P., Sepuri N. B. V., Anandatheerthavarada H. K., Selvaraj V., Hoek J., Milne G. L., Guengerich F. P., Avadhani N. G., Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. Journal of Biological Chemistry 2010 285 32 24609 24619 2-s2.0-77955294012 10.1074/jbc.M110.121822
45. Leclercq I. A., Farrell G. C., Field J., Bell D. R., Gonzalez F. J., Robertson G. R., CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. Journal of Clinical Investigation 2000 105 8 1067 1075 2-s2.0-0034092716 (Pubitemid 30217691)
46. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
47. Schildknecht S., Pape R., Müller N., Robotta M., Marquardt A., Bürkle A., Drescher M., Leist M., Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. Journal of Biological Chemistry 2011 286 7 4991 5002 2-s2.0-79953151438 10.1074/jbc.M110.169565
48. Radi R., Beckman J. S., Bush K. M., Freeman B. A., Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 1991 266 7 4244 4250 2-s2.0-0025730414 (Pubitemid 21909347)
49. Lancaster J. R., Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chemical Research in Toxicology 2006 19 9 1160 1174 2-s2.0-33749005136 10.1021/tx060061w (Pubitemid 44454032)
50. Malinski T., Nitric oxide and nitroxidative stress in Alzheimer's disease. Journal of Alzheimer's Disease 2007 11 2 207 218 2-s2.0-34347383021 (Pubitemid 47018067)
51. Calcerrada P., Peluffo G., Radi R., Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Current Pharmaceutical Design 2011 17 35 3905 3932
52. Broniowska K. A., Hogg N., The chemical biology of S -nitrosothiols. Antioxidants & Redox Signaling 2012 17 7 969 980
53. Minko I. G., Kozekov I. D., Harris T. M., Rizzo C. J., Lloyd R. S., Stone M. P., Chemistry and biology of DNA containing 1, N2 -deoxyguanosine adducts of the α β -unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chemical Research in Toxicology 2009 22 5 759 778 2-s2.0-67649933847 10.1021/tx9000489
54. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
55. Berlett B. S., Stadtman E. R., Protein oxidation in aging, disease, and oxidative stress. Journal of Biological Chemistry 1997 272 33 20313 20316 2-s2.0-0030841350 10.1074/jbc.272.33.20313 (Pubitemid 27355575)
56. Wan J., Bae M. A., Song B. J., Acetoaminophen-induced accumulation of 8-oxodeoxyguanosine through reduction of Ogg1 DNA repair enzyme in C6 glioma cells. Experimental and Molecular Medicine 2004 36 1 71 77 2-s2.0-1642303102 (Pubitemid 38374727)
57. Mansouri A., Fromenty B., Berson A., Robin M. A., Grimbert S., Beaugrand M., Erlinger S., Pessayre D., Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. Journal of Hepatology 1997 27 1 96 102 2-s2.0-0030806434 10.1016/S0168-8278(97)80286-3 (Pubitemid 27357061)
58. Mansouri A., Gaou I., De Kerguenec C., Amsellem S., Haouzi D., Berson A., Moreau A., Feldmann G., Letteron P., Pessayre D., Fromenty B., An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999 117 1 181 190 2-s2.0-0032990245 10.1016/S0016-5085(99) 70566-4 (Pubitemid 29297636)
59. Venkatraman A., Landar A., Davis A. J., Chamlee L., Sanderson T., Kim H., Page G., Pompilius M., Ballinger S., Darley-Usmar V., Bailey S. M., Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. Journal of Biological Chemistry 2004 279 21 22092 22101 2-s2.0-2542475915 10.1074/jbc.M402245200 (Pubitemid 38679401)
60. Doorn J. A., Hurley T. D., Petersen D. R., Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chemical Research in Toxicology 2006 19 1 102 110 2-s2.0-31844443064 10.1021/tx0501839 (Pubitemid 43185467)
61. Fritz K. S., Galligan J. J., Smathers R. L., Roede J. R., Shearn C. T., Reigan P., Petersen D. R., 4-hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chemical Research in Toxicology 2011 24 5 651 662 2-s2.0-79956150193 10.1021/tx100355a
62. Rubbo H., Radi R., Protein and lipid nitration: role in redox signaling and injury. Biochimica et Biophysica Acta 2008 1780 11 1318 1324 2-s2.0-49349115115 10.1016/j.bbagen.2008.03.007
63. Wells P. G., Mccallum G. P., Chen C. S., Henderson J. T., Lee C. J. J., Perstin J., Preston T. J., Wiley M. J., Wong A. W., Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicological Sciences 2009 108 1 4 18 2-s2.0-61349091797 10.1093/toxsci/kfn263
64. Cederbaum A. I., Lieber C. S., Rubin E., Effects of chronic ethanol treatment on mitochondrial functions damage to coupling site I. Archives of Biochemistry and Biophysics 1974 165 2 560 569 2-s2.0-0016363137
65. Chen J., Robinson N. C., Schenker S., Frosto T. A., Henderson G. I., Formation of 4-hydroxynonenal adducts with cytochrome c oxidase in rats following short-term ethanol intake. Hepatology 1999 29 6 1792 1798 2-s2.0-0032996250 10.1002/hep.510290611 (Pubitemid 29247053)
66. Chen J., Petersen D. R., Schenker S., Henderson G. I., Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol mediated inhibition of cytochrome c oxidase. Alcoholism 2000 24 4 544 552 2-s2.0-0034060591 (Pubitemid 30244254)
67. Moon K. H., Hood B. L., Kim B. J., Hardwick J. P., Conrads T. P., Veenstra T. D., Song B. J., Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 2006 44 5 1218 1230 2-s2.0-33751003258 10.1002/hep.21372 (Pubitemid 44748372)
68. Lu H., Koshkin V., Allister E. M., Gyulkhandanyan A. V., Wheeler M. B., Molecular and metabolic evidence for mitochondrial defects associated with β -cell dysfunction in a mouse model of type 2 diabetes. Diabetes 2010 59 2 448 459 2-s2.0-77449154126 10.2337/db09-0129
69. Menzies K. J., Robinson B. H., Hood D. A., Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects. American Journal of Physiology 2009 296 2 C355 C362 2-s2.0-60849098436 10.1152/ajpcell.00415.2007
70. Moon K. H., Hood B. L., Mukhopadhyay P., Rajesh M., Abdelmegeed M. A., Kwon Y. I., Conrads T. P., Veenstra T. D., Song B. J., Pacher P., Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008 135 4 1344 1357 2-s2.0-53249125859 10.1053/j.gastro.2008.06.048
71. Marchitti S. A., Brocker C., Stagos D., Vasiliou V., Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opinion on Drug Metabolism and Toxicology 2008 4 6 697 720 2-s2.0-48949117163 10.1517/17425255.4.6.697 (Pubitemid 352003194)
72. Black W. J., Stagos D., Marehitti S. A., Neberr D. W., Tipton K. F., Bairoch A., Vasiliou V., Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature. Pharmacogenetics and Genomics 2009 19 11 893 902 2-s2.0-74049098559 10.1097/FPC.0b013e3283329023
73. Hartley D. P., Ruth J. A., Petersen D. R., The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Archives of Biochemistry and Biophysics 1995 316 1 197 205 2-s2.0-0028842190 10.1006/abbi.1995.1028
74. Murphy T. C., Amarnath V., Picklo M. J., Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex. Journal of Neurochemistry 2003 84 6 1313 1321 2-s2.0-0037347447 10.1046/j.1471-4159.2003.01628.x (Pubitemid 36343597)
75. Klyosov A. A., Rashkovetsky L. G., Tahir M. K., Keung W. M., Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 1996 35 14 4445 4456 2-s2.0-0029935028 10.1021/bi9521093 (Pubitemid 26113505)
76. Abdelmegeed M. A., Yoo S. H., Henderson L. E., Gonzalez F. J., Woodcroft K. J., Song B. J., PPAR α expression protects male mice from high fat-induced nonalcoholic fatty liver. Journal of Nutrition 2011 141 4 603 610 2-s2.0-79955504163 10.3945/jn.110.135210
77. Mitchell D. Y., Petersen D. R., Inhibition of rat liver aldehyde dehydrogenases by acrolein. Drug Metabolism and Disposition 1988 16 1 37 42 2-s2.0-0023853526 (Pubitemid 18057094)
78. Landin J. S., Cohen S. D., Khairallah E. A., Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicology and Applied Pharmacology 1996 141 1 299 307 2-s2.0-0030296545 10.1006/taap.1996.0287 (Pubitemid 26414377)
79. Lipsky J. J., Shen M. L., Naylor S., Overview-in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chemico-Biological Interactions 2001 130-132 81 91 2-s2.0-0035969887 10.1016/S0009-2797(00)00224-6 (Pubitemid 32295805)
80. Chen C.-H., Budas G. R., Churchill E. N., Disatnik M. H., Hurley T. D., Mochly-Rosen D., Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008 321 5895 1493 1495 2-s2.0-51749104191 10.1126/science.1158554
81. Palmer K. R., Jenkins W. J., Aldehyde dehydrogenase in alcoholic subjects. Hepatology 1985 5 2 260 263 (Pubitemid 15116005)
82. Banfi P., Lanzi C., Falvella F. S., Gariboldi M., Gambetta R. A., Dragani T. A., The daunorubicin-binding protein of M(r) 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines. Molecular Pharmacology 1994 46 5 896 900 2-s2.0-0028171392
83. Park K. S., Cho S. Y., Kim H., Paik Y. K., Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. International Journal of Cancer 2002 97 2 261 265 2-s2.0-0037049991 10.1002/ijc.1585 (Pubitemid 34019964)
84. Moon K. H., Abdelmegeed M. A., Song B. J., Inactivation of cytosolic aldehyde dehydrogenase via S -nitrosylation in ethanol-exposed rat liver. FEBS Letters 2007 581 21 3967 3972 2-s2.0-34547666779 10.1016/j.febslet.2007.07.037 (Pubitemid 47212111)
85. Moon K. H., Kim B. J., Song B. J., Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S -nitrosylation. FEBS Letters 2005 579 27 6115 6120 2-s2.0-27544510276 10.1016/j.febslet.2005.09.082 (Pubitemid 41546257)
86. Song B. J., Abdelmegeed M. A., Yoo S.-H., Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. Journal of Proteomics 2011 74 12 2691 2702
87. Venkatraman A., Landar A., Davis A. J., Ulasova E., Page G., Murphy M. P., Darley-Usmar V., Bailey S. M., Oxidative modification of hepatic mitochondria protein thiols: effect of chronic alcohol consumption. American Journal of Physiology 2004 286 4 G521 G527 2-s2.0-1642325261 (Pubitemid 38374970)
88. Brocker C., Lassen N., Estey T., Pappa A., Cantore M., Orlova V. V., Chavakis T., Kavanagh K. L., Oppermann U., Vasiliou V., Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. Journal of Biological Chemistry 2010 285 24 18452 18463 2-s2.0-77953307970 10.1074/jbc.M109.077925
89. Moon K. H., Lee Y. M., Song B. J., Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. Free Radical Biology and Medicine 2010 48 3 391 398 2-s2.0-73449119542 10.1016/j.freeradbiomed.2009.11.008
90. Sampey B. P., Korourian S., Ronis M. J., Badger T. M., Petersen D. R., Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcoholism 2003 27 6 1015 1022 2-s2.0-0037971533 (Pubitemid 36759392)
91. Upreti V. V., Eddington N. D., Moon K. H., Song B. J., Lee I. J., Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy"). Toxicology Letters 2009 188 2 167 172 2-s2.0-65549105425 10.1016/j.toxlet.2009.03.023
92. Abdelmegeed M. A., Moon K. H., Hardwick J. P., Gonzalez F. J., Song B. J., Role of peroxisome proliferator-activated receptor- α in fasting-mediated oxidative stress. Free Radical Biology and Medicine 2009 47 6 767 778 2-s2.0-68349131724 10.1016/j.freeradbiomed.2009.06.017
93. Johnston D. S., Su Y. A., Alesci S., Mitochondrial gene profiling: translational perspectives. Pharmacogenomics 2009 10 10 1645 1655 2-s2.0-70649111384 10.2217/pgs.09.112
94. Gygi S. P., Rochon Y., Franza B. R., Aebersold R., Correlation between protein and mRNA abundance in yeast. Molecular and Cellular Biology 1999 19 3 1720 1730 2-s2.0-0033016717 (Pubitemid 29098230)
95. Kozlov A. V., Duvigneau J. C., Miller I., Nürnberger S., Gesslbauer B., Kungl A., Öhlinger W., Hartl R. T., Gille L., Staniek K., Gregor W., Haindl S., Redl H., Endotoxin causes functional endoplasmic reticulum failure, possibly mediated by mitochondria. Biochimica et Biophysica Acta 2009 1792 6 521 530 2-s2.0-67349208432 10.1016/j.bbadis.2009.03.004
96. Tonge R. P., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., Pognan F., Hawkins E., Currie I., Davison M., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001 1 3 377 396 2-s2.0-0035289178 (Pubitemid 33585112)
97. Sethuraman M., McCombs M. E., Heibeck T., Costellos C. E., Cohen R. A., Isotope-coded affinity tag approach to identify and quantify oxidant-sensitive protein thiols. Molecular and Cellular Proteomics 2004 3 3 273 278 2-s2.0-2642576571 10.1074/mcp.T300011-MCP200 (Pubitemid 38714283)
98. Wu W. W., Wang G., Baek S. J., Shen R. F., Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. Journal of Proteome Research 2006 5 3 651 658 2-s2.0-33644845960 10.1021/pr050405o (Pubitemid 43364106)
99. Washburn M. P., Wolters D., Yates J. R., Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nature Biotechnology 2001 19 3 242 247 2-s2.0-0035106351 10.1038/85686 (Pubitemid 32220565)
100. Ünlü M., Morgan M. E., Minden J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997 18 11 2071 2077 2-s2.0-0343376097 (Pubitemid 27501267)
101. Kim B. J., Ryu S. W., Song B. J., JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. Journal of Biological Chemistry 2006 281 30 21256 21265 2-s2.0-33746379603 10.1074/jbc.M510644200 (Pubitemid 44115465)
102. Yang Y., Cimen H., Han M. J., Shi T., Deng J. H., Koc H., Palacios O. M., Montier L., Bai Y., Tong Q., Koc E. C., NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. Journal of Biological Chemistry 2010 285 10 7417 7429 2-s2.0-77951235122 10.1074/jbc.M109.053421
103. Hu Y., Suarez J., Fricovsky E., Wang H., Scott B. T., Trauger S. A., Han W., Hu Y., Oyeleye M. O., Dillmann W. H., Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. Journal of Biological Chemistry 2009 284 1 547 555 2-s2.0-58649095123 10.1074/jbc.M808518200
104. Kim J. R., Yoon H. W., Kwon K. S., Lee S. R., Rhee S. G., Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Analytical Biochemistry 2000 283 2 214 221 2-s2.0-0034255470 10.1006/abio.2000.4623 (Pubitemid 30626272)
105. Suh S. K., Hood B. L., Kim B. J., Conrads T. P., Veenstra T. D., Song B. J., Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics 2004 4 11 3401 3412 2-s2.0-8744304760 10.1002/pmic.200400971 (Pubitemid 39525289)
106. Song B. J., Suh S. K., Moon K. H., A simple method to systematically study oxidatively modified proteins in biological samples and its applications. Methods in Enzymology 2010 473 251 264 2-s2.0-77956219883
107. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., Colombo R., Rossi R., Milzani A., Proteins as biomarkers of oxidattiv/e/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrometry Reviews 2005 24 1 55 99 2-s2.0-12444296480 10.1002/mas.20006 (Pubitemid 40146422)
108. Derakhshan B., Wille P. C., Gross S. S., Unbiased identification of cysteine S -nitrosylation sites on proteins. Nature Protocols 2007 2 7 1685 1691 2-s2.0-34548571932 10.1038/nprot.2007.210
109. Kettenhofen N. J., Wang X., Gladwin M. T., Hogg N., In-gel detection of S -nitrosated proteins using fluorescence methods. Methods in Enzymology 2008 441 53 71 2-s2.0-52049105346 10.1016/S0076-6879(08)01204-4
110. Chiappetta G., Ndiaye S., Igbaria A., Kumar C., Vinh J., Toledano M. B., Proteome screens for Cys residues oxidation: the redoxome. Methods in Enzymology 2010 473 199 216 2-s2.0-77956205107
111. Andringa K. K., Bailey S. M., Detection of protein thiols in mitochondrial oxidative phosphorylation complexes and associated proteins. Methods in Enzymology 2010 474 83 108 2-s2.0-79958022486
112. Chouchani E. T., James A. M., Fearnley I. M., Lilley K. S., Murphy M. P., Proteomic approaches to the characterization of protein thiol modification. Current Opinion in Chemical Biology 2011 15 1 120 128 2-s2.0-79851514956 10.1016/j.cbpa.2010.11.003
113. Kashiba-Iwatsuki M., Kitoh K., Kasahara E., Yu H., Nisikawa M., Matsuo M., Inoue M., Ascorbic acid and reducing agents regulate the fates and functions of S -nitrosothiols. Journal of Biochemistry 1997 122 6 1208 1214 2-s2.0-0031473520 (Pubitemid 28019987)
114. Jaffrey S. R., Snyder S. H., The biotin switch method for the detection of S -nitrosylated proteins. Sciences STKE 2001 2001 86 PL1 2-s2.0-0035849715
115. Gladwin M. T., Wang X., Hogg N., Methodological vexation about thiol oxidation versus S commentary on 'An ascorbate-dependent artifact that interferes with the interpretation of the biotin-switch assay'. Free Radical Biology and Medicine 2006 41 4 557 561 2-s2.0-33746085196 10.1016/j. freeradbiomed.2006.05.025 (Pubitemid 44080518)
116. Huang B., Chen C., An ascorbate-dependent artifact that interferes with the interpretation of the biotin switch assay. Free Radical Biology and Medicine 2006 41 4 562 567 2-s2.0-33746070773 10.1016/j.freeradbiomed.2006.03.006 (Pubitemid 44080503)
117. 6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994 15 3 443 447 2-s2.0-0028181674 (Pubitemid 24121689)
118. Ahn B. H., Kim H. S., Song S., In H. L., Liu J., Vassilopoulos A., Deng C. X., Finkel T., A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14447 14452 2-s2.0-55749084738 10.1073/pnas.0803790105
119. Hirschey M. D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D. B., Grueter C. A., Harris C., Biddinger S., Ilkayeva O. R., Stevens R. D., Li Y., Saha A. K., Ruderman N. B., Bain J. R., Newgard C. B., Farese R. V., Alt F. W., Kahn C. R., Verdin E., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010 464 7285 121 125 2-s2.0-77950806433 10.1038/nature08778
120. Kendrick A. A., Choudhury M., Rahman S. M., McCurdy C. E., Friederich M., Van Hove J. L. K., Watson P. A., Birdsey N., Bao J., Gius D., Sack M. N., Jing E., Kahn C. R., Friedman J. E., Jonscher K. R., Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochemical Journal 2011 433 3 505 514 2-s2.0-78751513117 10.1042/BJ20100791
121. Gow A. J., Duran D., Malcolm S., Ischiropoulos H., Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Letters 1996 385 1-2 63 66 2-s2.0-0030002384 10.1016/0014-5793(96)00347-X (Pubitemid 26153471)
122. Widmer R., Kaiser B., Engels M., Jung T., Grune T., Hyperammonemia causes protein oxidation and enhanced proteasomal activity in response to mitochondria-mediated oxidative stress in rat primary astrocytes. Archives of Biochemistry and Biophysics 2007 464 1 1 11 2-s2.0-34447631179 10.1016/j.abb.2007.03.027 (Pubitemid 47088356)
123. Polge C., Jaquinod M., Holzer F., Bourguignon J., Walling L., Brouquisse R., Evidence for the existence in Arabidopsis thaliana of the proteasome proteolytic pathway: activation in response to cadmium. Journal of Biological Chemistry 2009 284 51 35412 35424 2-s2.0-72149105595 10.1074/jbc.M109.035394
124. Abdelmegeed M. A., Moon K. H., Chen C., Gonzalez F. J., Song B. J., Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochemical Pharmacology 2010 79 1 57 66 2-s2.0-70350202531 10.1016/j.bcp.2009.07.016
125. Robin M. A., Demeilliers C., Sutton A., Paradis V., Maisonneuve C., Dubois S., Poirel O., Lettéron P., Pessayre D., Fromenty B., Alcohol increases tumor necrosis factor α and decreases nuclear factor- B to activate hepatic apoptosis in genetically obese mice. Hepatology 2005 42 6 1280 1290 2-s2.0-28844465328 10.1002/hep.20949 (Pubitemid 43260030)
126. Hardwick J. P., Osei-Hyiaman D., Wiland H., Abdelmegeed M. A., Song B. J., PPAR/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease. PPAR Research 2009 2009 952734 10.1155/2009/952734
127. Fischer M., You M., Matsumoto M., Crabb D. W., Peroxisome proliferator-activated receptor α (PPAR α) agonist treatment reverses PPAR α dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. Journal of Biological Chemistry 2003 278 30 27997 28004 2-s2.0-0042847330 10.1074/jbc.M302140200 (Pubitemid 36899995)
128. Donthamsetty S., Bhave V. S., Mitra M. S., Latendresse J. R., Mehendale H. M., Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPAR α with clofibrate.
129. Chen C., Krausz K. W., Shah Y. M., Idle J. R., Gonzalez F. J., Serum metabolomics reveals irreversible inhibition of fatty acid β -oxidation through the suppression of PPAR α activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chemical Research in Toxicology 2009 22 4 699 707 2-s2.0-66049157560 10.1021/tx800464q
130. Shakunthala N., New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochrome. Expert Opinion on Drug Metabolism and Toxicology 2010 6 1 1 15 2-s2.0-72949090555 10.1517/17425250903329095
131. Catalá A., Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chemistry and Physics of Lipids 2009 157 1 1 11 2-s2.0-57249095767 10.1016/j.chemphyslip.2008.09.004
132. Andringa K. K., Bajt M. L., Jaeschke H., Bailey S. M., Mitochondrial protein thiol modifications in acetaminophen hepatotoxicity: effect on HMG-CoA synthase. Toxicology Letters 2008 177 3 188 197 2-s2.0-40849137599 10.1016/j.toxlet.2008.01.010
133. Smathers R. L., Galligan J. J., Stewart B. J., Petersen D. R., Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chemico-Biological Interactions 2011 192 1-2 107 112 2-s2.0-79958058366 10.1016/j.cbi.2011.02.021
134. Kim B. J., Hood B. L., Aragon R. A., Hardwick J. P., Conrads T. P., Veenstra T. D., Song B. J., Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells. Proteomics 2006 6 4 1250 1260 2-s2.0-33644500142 10.1002/pmic.200500447
135. Upreti V. V., Moon K. H., Yu L. R., Lee I. J., Eddington N. D., Ye X., Veenstra T. D., Song B. J., Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver. Proteomics 2011 11 2 202 211 2-s2.0-78650764265 10.1002/pmic.201000203
136. Abdelmegeed M. A., Banerjee A., Yoo S. H., Jang S. H., Gonzalez F. J., Song B. J., Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. Journal of Hepatology 2012 57 4 860 866
137. Song B. J., Moon K. H., Olsson N. U., Salem N., Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. Journal of Hepatology 2008 49 2 262 273 2-s2.0-46149111662 10.1016/j.jhep.2008.04.023
138. Pawlosky R. J., Flynn B. M., Salem N. Jr., The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in rhesus monkeys. Hepatology 1997 26 6 1386 1392 2-s2.0-0030683505 (Pubitemid 27520000)
139. Takayama F., Nakamoto K., Totani N., Yamanushi T., Kabuto H., Kaneyuki T., Mankura M., Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Journal of Oleo Science 2010 59 8 407 414 2-s2.0-77954353061
140. Seitz H. K., Lieber C. S., Stickel F., Salaspuro M., Schlemmer H. P., Horie Y., Alcoholic liver disease: from pathophysiology to therapy. Alcoholism 2005 29 7 1276 1281 2-s2.0-23044449375 10.1097/01.ALC.0000171896.37022.F7 (Pubitemid 41060445)
141. Okiyama W., Tanaka N., Nakajima T., Tanaka E., Kiyosawa K., Gonzalez F. J., Aoyama T., Polyenephosphatidylcholine prevents alcoholic liver disease in PPAR α -null mice through attenuation of increases in oxidative stress. Journal of Hepatology 2009 50 6 1236 1246 2-s2.0-67349132443 10.1016/j.jhep.2009.01.025
142. Bailey S. M., Robinson G., Pinner A., Chamlee L., Ulasova E., Pompilius M., Page G. P., Chhieng D., Jhala N., Landar A., Kharbanda K. K., Ballinger S., Darley-Usmar V., S -adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. American Journal of Physiology 2006 291 5 G857 G867 2-s2.0-33751082953 10.1152/ajpgi.00044.2006 (Pubitemid 44772012)
143. Kasdallah-Grissa A., Mornagui B., Aouani E., Hammami M., El May M., Gharbi N., Kamoun A., El-Fazaâ S., Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sciences 2007 80 11 1033 1039 2-s2.0-33846796318 10.1016/j.lfs.2006.11.044 (Pubitemid 46204723)
144. Darvesh A. S., Carroll R. T., Bishayee A., Geldenhuys W. J., Van der Schyf C. J., Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Review of Neurotherapeutics 2010 10 5 729 745 2-s2.0-77951867859 10.1586/ern.10.42
145. Ha H. L., Shin H. J., Feitelson M. A., Yu D. Y., Oxidative stress and antioxidants in hepatic pathogenesis. World Journal of Gastroenterology 2010 16 48 6035 6043 2-s2.0-78650780107 10.3748/wjg.v16.i48.6035
146. Abreu R. M. V., Santos D. J. S. L., Moreno A. J. M., Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. Journal of Pharmacology and Experimental Therapeutics 2000 295 3 1022 1030 2-s2.0-0033681003